Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases
Clinical trial NCT07322718 · RECRUITING
Trial details
- NCT number
- NCT07322718
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-24
- Primary completion
- 2027-12-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.